Dr. Reddy's Laboratories Ltd. (RDY) Announces the Launch of Montelukast Sodium Oral Granules  
9/27/2012 9:43:35 AM

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair® (montelukast sodium) oral granules in the US market on September, 26, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr.Reddy’s ANDA for Montelukast Sodium Oral Granules.